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Abstract: Women with previously diagnosed gestational diabetes mellitus (GDM) are at increased
risk of type-2-diabetes mellitus (T2D). We aimed to establish links between glucose tolerance (GT)
and serum fatty acid (FA) profile in the transition from GDM to T2D. Six years after GDM, 221 women
were grouped as having normal GT (NGT), impaired GT (IGT), or T2D based on oral GT test
results. Fasting serum FAs were profiled, anthropometric measures taken, and dietary intake
determined. Linoleic acid (LA) was significantly higher in NGT women (p < 0.001) compared with
IGT and T2D, and emerged as a strong predictor of low glucose and insulin levels, independently
of BMI. Self-reported vegetable oil consumption correlated with LA serum levels and glucose
levels. Delta-6-, delta-9-, and stearoyl-CoA-desaturase activities were associated with decreased GT,
and delta-5-desaturase activities with increased GT. In a subgroup of women at high risk of diabetes,
low LA and high palmitic acid levels were seen in those that developed T2D, with no differences in
other FAs or metabolic measurements. Results suggest that proportions of LA and palmitic acid are
of particular interest in the transition from GDM to T2D. Interconversions between individual FAs
regulated by desaturases appear to be relevant to glucose metabolism.
Keywords: gestational diabetes mellitus; serum fatty acids; linoleic acid; glucose tolerance
1. Introduction
Gestational diabetes mellitus (GDM), defined as glucose intolerance with onset or first recognition
during pregnancy, has short- and long-term implications for both mother and child [1,2]. In the mother,
it confers increased risk of developing glucose intolerance later in life. In fact, the risk factors for GDM
and T2D are the same, and it has been suggested that the inherent insulin-resistant state of pregnancy
may reveal a pre-disposition for T2D. Even though normal glucose tolerance is typically resumed
after birth, women with a prior diagnosis of GDM have a sevenfold increased risk of developing T2D
later in life [3]. The risk increases over the first 5 years after giving birth, reaching a plateau after 10
years [4]. The years immediately after a GDM pregnancy, therefore, represent an important window
for close health surveillance and intervention in order to prevent the development of T2D.
Fatty acids (FAs) are believed to play an important role in the progression of insulin resistance
and T2D. Both the total amount of circulating FAs, and the relationship between different types
of FAs, may impact on functions such as membrane fluidity, regulation of substrate oxidation,
appetite receptor activation, inflammation, glucose transporter inhibition, lipotoxicity, and beta-cell
function, which are all important in the development of metabolic disease [5–8]. In recent
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years, nutritional recommendations have shifted to focus more on fat quality than fat quantity,
with observational studies showing that substituting dietary saturated FAs (SFAs) with mono-
or poly-unsaturated FAs (MUFAs and PUFAs, respectively) is associated with improved insulin
sensitivity [6,9].
Serum FA levels, which depend both on dietary intake and synthesis/degradation within
the body, provide a more objective measure of FA levels than estimates based on dietary intake;
some circulating FAs correlate well with dietary intake (e.g., linoleic acid (LA), eicosapentaenoic acid
(EPA), and docosahexaenoic acid (DHA)), whereas others show weaker correlations with dietary
measures (e.g., α-linolenic acid (ALA)) [10]. Relative serum levels of individual FAs also give
information on the conversion rates between different FAs, and allow estimation of the activity
of key enzymes such as the FA desaturases, which seem to play a role in the development of T2D [11].
Although there are limited studies on individual circulating FAs and T2D, it is clear that high
serum levels of saturated FAs are generally associated with increased risk of T2D [12–14], whereas there
have been mixed reports on the relationship between serum levels of individual MUFAs and PUFAs
and T2D [15–19]. A majority of these studies to date have been conducted in elderly or middle-aged
populations and so it is of interest to explore whether the same patterns hold true in younger
populations, in this case a younger population of women with increased risk of T2D. Though a
few reports exist on FAs during diabetic pregnancies [20–22], to our knowledge, only one prior study
has analysed circulating levels of individual FAs after GDM [23]. This study was performed soon
after birth, showed associations of specific FAs with overweight and adiposity, but failed to show a
link to insulin resistance. Our aim is to use FA-profiling to explore associations between individual
FAs/desaturase activities and glucose tolerance in women six years after GDM, in order to identify
biomarkers that are related to development of impaired glucose tolerance and T2D.
2. Materials and Methods
2.1. Subjects
The study was approved by the ethics committee at the University of Gothenburg (402-08/750-15).
Informed consent was obtained from all participants. A group of 542 women in the Gothenburg area
who were diagnosed with GDM from 2005 to 2009 were invited to participate in the study; 378 of this
group were interviewed by telephone and asked to attend a follow-up visit. The study group included
the 237 women who attended the follow up visit 5.6 ± 0.5 years after pregnancy, and has previously
been described in detail [24].
2.2. Protocol
At follow-up visit, fasting blood samples were collected from all participants. Women who had
not been diagnosed with diabetes since pregnancy also underwent a 2-h 75 g oral glucose tolerance
test (OGTT). Venous blood for analysis of plasma glucose and serum insulin was collected at 0
(fasting value), 30, 60, 90, and 120 min. Fasting serum and plasma blood samples were used for
further analysis.
During the visit, anthropometric variables (weight, height, waist and hip circumference) and
resting blood pressure were measured, and participants were asked to complete dietary and lifestyle
questionnaires, as previously described [24]. Dietary intake was assessed using a semi-quantitative
food frequency questionnaire; the questionnaire has previously been validated in Swedish men
and women against a 4-day food record and 24-h energy expenditure and nitrogen excretion [25].
Only correctly completed questionnaires were used for analysis. Basal metabolic rate (BMR) was
calculated using the Henry equation [26]; subjects with an energy intake (EI)/BMR ratio <0.95 or >3.0
were excluded from energy and macronutrient analyses. Frequency of meals containing meat, fish,
or vegetarian options was determined based on specific questions. Participants were further asked
to estimate quantities of different cooking fats used, allowing assessment of the proportion of butter,
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margarine and vegetable oil within the diet. Educational level was based on the women’s highest
attained level and classified as elementary school (level 0), 2 years of high school (level 1), 3 years of
high school (level 2), <3 years of university (level 3) or ≥3 years of university (level 4). At a second
follow-up visit, body composition was measured by BOD POD (software version 5.4.0, Cosmed, Rome,
Italy) in a subgroup of 87 women.
2.3. Glucose Tolerance Groups
Women were split into three groups based on findings at 6-year follow-up: normal glucose
tolerance (NGT), IGT (including impaired fasting glucose or impaired glucose tolerance), and T2D
(including subjects with previously diagnosed T2D), as previously described [24]. Classification of
NGT, IGT, and T2D was based on the 1999 WHO guidelines [27]; NGT, fasting glucose < 6.1 mmol/L
and 2-h glucose < 7.8 mmol/L; IGT, fasting glucose ≥ 6.1 and <7.0 mmol/L and/or 2-h glucose ≥ 7.8
and <11.1 mmol/L; T2D, fasting glucose≥ 7.0 mmol/L or 2-h glucose≥ 11.1 mmol/L. Individuals with
confirmed type 1 diabetes mellitus at follow-up (n = 8) were excluded from the analysis.
For the T2D group, diagnosis was on average 1.1 ± 1.6 years before the study visit (date of
diagnosis ranged from 5 years before study visit to at study visit). There were no differences in levels
of any FA studied between those with previously known (n = 21) and newly diagnosed T2D (n = 22);
time of diagnosis was not associated with any FA measurements. Women with T2D were therefore
treated as a single group.
2.4. Biochemical Measurements
HbA1c was analysed immediately with a point-of-care analyser (Afinion AS100; Axis-Shield, Oslo,
Norway). Glucose, insulin, cholesterol (total, low-density lipoprotein (LDL), and high-density lipoprotein
(HDL)), and triglycerides were analysed at the accredited Clinical Chemistry Laboratory, Sahlgrenska
University Hospital (International Standard ISO 15189:2007). The homeostatic model assessment of insulin
resistance (HOMA-IR) was calculated as (fasting glucose × fasting insulin)/22.5 [28].
2.5. Fatty Acid Analysis
Fasting serum samples for FA analysis were available from 221 women. Serum FA composition
was determined in duplicate samples as FAME by direct methylation of 50 µL serum samples [29].
To each sample, was added 25 µg C17 (Larodan, Stockholm, Sweden) as internal standard, 1 mL Acetyl
chloride 10% in Methanol, and 1 mL Toluene. Methylation occurred in tightly closed tubes placed in a
70 ◦C water bath for 2 h and shaken every 30 min. After cooling, 3 mL petroleum ether and 0.5 mL H2O
were added, and the tubes shaken and centrifuged mildly (2500 rpm) for 5 min at room temperature.
Then the upper phase was withdrawn and evaporated at 40 ◦C under a stream of N2, and the FA residue
was dissolved in 200 µL iso-octane. The methylated samples were injected into an Agilent 7890 A GC
system equipped with a VF-WAXms (30 m × 0.25 mm × 0.25 µm df) column (Agilent J&W Scientific,
Santa Clara, CA, USA) and interfaced with a Agilent 5975 C triple-axis mass spectrometric detector in
electron-impact mode. Injection volume was 1 µL with a 15:1 split ratio at an inlet temperature of 275 ◦C.
The carrier gas was Helium at a fixed flow of 1 mL/min. The temperature program was as follows:
100 ◦C for 0 min, increasing by 4 ◦C/min to 205 C, thereafter increasing at 1 ◦C/min up to 230 ◦C,
followed by 5 min at 230 ◦C. External standard GLC-463 (Nu-Chec prep, Inc., Elysian, MN, USA) was
used for identification and quantification. FA concentrations were calculated as percentages of total
FAs, and desasturase activities were estimated by the ratios 20:3n6/18:2n6 (delta-6-desaturase, D6D),
20:4n6/20:3n6 (delta-5-desaturase, D5D), 16:1n7/16:0 (Stearoyl-CoA desaturase, SCD) and 18:1n9/18:0
(delta-9-desaturase, D9D).
2.6. Statistical Analysis
For between-group comparisons, ANOVA and ANCOVA (with BMI as covariate and with the
assumption of homogeneity of regression slopes fulfilled) were used with Tukey post-hoc analysis.
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Pearson bivariate and partial correlations (with BMI as covariate) were performed on overall data
from all participants. Stepwise regression was performed for HOMA-IR with all FAs entered as
independent variables. All analyses were conducted using IBM SPSS version 23.0 (IBM SPSS Statistics,
Armonk, NY, USA). Values are expressed as mean ± SD. P < 0.05 was considered significant.
3. Results
3.1. Background Characteristics
At the 6-year follow-up visit, 135 women had NGT, 43 women had IGT, and 43 had T2D. Table 1
shows characteristics of the three groups. BMI, fat mass, and waist and hip circumference were
significantly greater in women in the IGT and T2D groups compared with the NGT group. Women with
IGT or T2D also had significantly lower HDL-cholesterol levels than women with NGT, and women
with T2D had significantly higher triglyceride levels compared with those with NGT. Smoking rate
and alcohol intake did not differ between groups. Fewer of the T2D group were of Scandinavian origin
compared with the other two groups, and they had lower level of education. All glucose, HbA1c,
and insulin measurements were higher in the IGT and T2D groups compared with the NGT group
(Table 1). Based on self-reported dietary intake (Table 2), there were no differences between groups in
energy intake, macronutrient intake, or specific meal frequencies. However, there were differences
in the proportions of different cooking fats used between groups; women with T2D reported using a
significantly greater proportion of margarine than women with NGT, while women with T2D or IGT
reported using a significantly lower proportion of butter than women with NGT.
Table 1. Characteristics of women 6 years after a GDM pregnancy. Women were divided into glucose
tolerance groups based on OGTT at 6-year visit; type 2 diabetes (T2D) was determined by OGTT at
time of diagnosis or at 6-year visit.
NGT IGT T2D P a
n Mean SD n Mean SD n Mean SD IGT vs.NGT
T2D vs.
NGT
T2D vs.
IGT
Age (years) 135 39.5 5.0 43 40.5 6.0 43 37.8 5.3 0.05
Ethnicity
(% Scandinavian) 130 53.1 43 51.2 43 32.6 0.023
Education level (0–4) 125 2.4 1.3 41 2.3 1.3 37 1.6 1.5 0.007
BMI (kg/m2) 135 26.1 4.9 43 29.5 4.6 43 29.2 5.8 <0.001 0.002
Waist circumference (cm) 133 87.4 10.8 42 94.0 16.7 43 95.0 14.6 0.007 0.004
Hip circumference (cm) 133 102.3 9.9 42 108.2 9.1 43 107.5 11.6 0.002 0.02
Body fat (%) 59 32.9 7.9 16 40.5 6.6 12 38.5 13.2 0.007
Fat mass (kg) 59 23.4 9.5 16 32.3 10.7 12 31.8 15.8 0.01 0.04
Fat free mass (kg) 59 45.6 5.4 16 46.0 6.7 12 45.9 6.0
BP systolic (mmHg) 134 114 13 43 123 14 43 119 14 <0.001
BP diastolic (mmHg) 134 75 10 43 79 10 43 78 11
s-Total cholesterol (mM) 135 4.7 0.8 43 4.7 0.8 42 4.7 0.7
s-HDL (mM) 135 1.5 0.3 43 1.3 0.3 43 1.4 0.5 0.001 0.04
s-LDL (mM) 135 2.9 0.8 43 3.2 0.7 43 3.0 0.6
s-Triglycerides (mM) 134 0.9 0.5 43 1.2 0.5 43 1.4 1.4 <0.001
Alcohol intake (g) 111 3.3 4.1 34 2.8 4.3 22 1.8 3.2
Smokers (%) 126 19.8 37 13.5 34 11.8
Glucose and insulin
b-HbA1c (mmol/mol) 135 37.1 3.7 42 38.4 3.9 43 52.7 19.0 <0.001 <0.001
p-Glucose fasting (mM) 135 5.4 0.4 42 6.1 0.4 43 8.2 3.5 0.02 <0.001 <0.001
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Table 1. Cont.
NGT IGT T2D P a
n Mean SD n Mean SD n Mean SD IGT vs.NGT
T2D vs.
NGT
T2D vs.
IGT
p-Glucose 2 h (mM) 125 5.5 1.1 41 7.7 1.6 12 11.8 3.9 <0.001 <0.001 <0.001
s-Insulin fasting (mU/L) 131 8.1 4.2 42 14.7 9.4 43 12.9 7.5 <0.001 <0.001
s-Insulin 2 h (mU/L) 119 45.0 37.8 39 87.8 57.7 12 85.3 58.4 <0.001 0.008
HOMA-IR 130 1.9 1.0 42 3.9 2.7 42 4.9 3.4 <0.001 <0.001 0.04
a Between-group comparisons based on ANOVA. b, whole blood; BP, blood pressure; BMI, body mass index;
GDM, gestational diabetes mellitus; HDL, high-density lipoprotein; HOMA-IR, homeostatic model assessment of
insulin resistance; IGT, impaired glucose tolerance; LDL, low-density lipoprotein; NGT, normal glucose tolerance;
p, plasma; s, serum; SD, standard deviation.
Table 2. Self-reported dietary intake of women 6 years after a GDM pregnancy. Women were divided
into glucose tolerance groups based on OGTT at 6 year visit; type 2 diabetes (T2D) was determined by
OGTT at time of diagnosis or at 6-year visit.
NGT (n = 88) IGT (n = 32) T2D (n = 17) P a P a BMI-Adjusted
Mean SD Mean SD Mean SD
IGT
vs.
NGT
T2D
vs.
NGT
T2D
vs.
IGT
IGT
vs.
NGT
T2D
vs.
NGT
T2D
vs.
IGT
Energy intake (kcal/d) 2399 551 2354 727 2248 590
Carbohydrate intake
(g/d) 251 66 251 87 232 73
Protein intake (g/d) 97 23 98 38 97 27
Fat intake (g/d) 108 32 103 33 101 30
Meal frequencies
Meat meals (per week) 7.8 3.5 7.9 2.3 7.3 3.2
Fish meals (per week) 2.6 1.9 2.7 1.5 3.0 2.5
Vegetarian meals
(per week) 1.4 2.4 0.6 1.3 0.7 1.5
Proportion of
cooking fat used
Butter (%) 32 31 17 25 12 20 0.03 0.03 0.01 0.01
Margarine (%) 24 30 36 36 51 36 0.01 0.004
Vegetable oil (%) 43 28 38 30 37 33
a Between-group comparisons based on ANOVA (P) and ANCOVA (BMI-adjusted P). BMI, body mass
index; GDM, gestational diabetes mellitus; IGT, impaired glucose tolerance; NGT, normal glucose tolerance;
SD, standard deviation.
3.2. Fatty Acid Profiles in NGT, IGT, and T2D Groups
Circulating FA profiles for the three groups are displayed in Table 3. Individual FAs are expressed
as a percentage of total FAs. Between-group differences were seen for PUFAs both before and after
adjustment for BMI; the amount of LA as a proportion of all FAs was significantly lower in women in
the IGT and T2D groups than in the NGT group, and proportions of GLA and DGLA were significantly
higher in women in the IGT group compared with those in the NGT group. The proportion of
docosapentaenoic acid (DPA) was higher in T2D than both other groups only after BMI adjustment.
For MUFAs, the proportion of palmitoleic acid (POA) was significantly higher in women in the IGT
and T2D groups, and the proportion of oleic acid was significantly higher in women in the IGT
group, compared with women with NGT. Only the proportion of POA for the IGT versus NGT group
remained significant after adjustment for BMI. Among the saturated FAs, the only between-group
difference in proportions was for palmitic acid which was significantly higher in the T2D versus the
NGT group both before and after adjustment for BMI.
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Table 3. Serum fatty acid (FA) composition 6 years after GDM, expressed as % of total FAs. Women were divided in glucose tolerance groups based on OGTT at 6 year
visit; type 2 diabetes (T2D) was determined by OGTT at time of diagnosis or at 6-year visit.
NGT (n = 135) IGT (n = 43) T2D (n = 43) P a P a BMI-Adjusted
Mean SD Mean SD Mean SD NGT vs.IGT
NGT vs.
T2D
IGT vs.
T2D
NGT vs.
IGT
NGT vs.
T2D
IGT vs.
T2D
ω-3 PUFAs, %
α-Linolenic acid ALA (18:3n3) 0.72 0.22 0.81 0.25 0.78 0.29
Eicosapentaenoic acid EPA (20:5n3) 0.90 0.54 1.00 0.67 0.95 0.45
Docosapentaenoic acid DPA (22:5n3) 0.41 0.09 0.40 0.08 0.45 0.12 0.007 0.036
Docosahexaenoic acid DHA (22:6n3) 1.77 0.61 1.72 0.61 1.70 0.64
ω-6 PUFAs, %
Linoleic acid LA (18:2n6) 30.1 3.8 27.6 3.8 27.1 4.2 0.001 <0.001 0.004 <0.001
γ-Linolenic acid GLA (18:3n6) 0.30 0.15 0.38 0.14 0.34 0.14 0.004 0.011
Dihomo-γ-linolenic acid DGLA (20:3n6) 1.25 0.31 1.42 0.34 1.36 0.40 0.013
Arachidonic acid AA (20:4n6) 6.06 1.36 6.09 1.09 6.00 1.34
MUFAs, %
Palmitoleic acid POA (16:1n7) 1.42 0.50 1.77 0.70 1.68 0.80 0.004 0.042 0.026
Vaccenic acid (18:1n7) 2.03 0.29 2.06 0.30 2.08 0.33
Oleic acid (18:1n9) 22.6 2.6 23.9 3.1 23.7 3.8 0.03
Saturated FAs, %
Myristic acid (14:0) 0.64 0.28 0.73 0.28 0.69 0.28
Palmitic acid (16:0) 23.5 2.1 23.9 2.0 24.7 2.3 0.002 0.003
Stearic acid (18:0) 8.41 0.94 8.32 0.77 8.49 1.24
Desaturase activity
Delta-6 desaturase D6D (DGLA/LA) 0.047 0.015 0.058 0.016 0.056 0.017 <0.001 0.002 0.002 0.010
Delta-5 desaturase D5D (AA/DGLA) 5.3 1.9 4.7 1.7 4.8 1.7
Stearoyl-CoA desaturase SCD (16:1n7/16:0) 0.060 0.018 0.073 0.024 0.067 0.027 0.003 0.02
Delta-9 desaturase D9D (18:1n9/18:0) 2.8 0.5 2.9 0.5 2.8 0.6
a Between-group comparisons based on ANOVA (P) and ANCOVA (BMI-adjusted P). BMI, body mass index; CoA, coenzyme A; GDM, gestantional diabetes mellitus; IGT, impaired glucose
tolerance; MUFA, monounsaturated fatty acid; NGT, normal glucose tolerance; PUFA, polyunsaturated fatty acid; SD, standard deviation.
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Delta-6 desaturase activity (D6D) was found to be higher in women in the IGT and T2D groups
than in the NGT group, and stearoyl-CoA desaturase (SCD) activity was higher in the IGT compared
with the NGT group. Differences remained after adjustment for BMI. There were no significant
differences for delta-5 (D5D) or delta-9 desaturase.
3.3. Correlation between FAs and Clinical Measurements for All Women
DHA and LA correlated inversely with BMI (Table 4), whereas GLA, DGLA, POA, and oleic
acid correlated positively with BMI. LA also correlated negatively with hip and waist circumference,
blood pressure (systolic and diastolic), and % body fat, and DHA with waist and hip circumference.
Positive correlations with anthropometric data were found for GLA, DGLA, POA, and oleic acid.
Saturated myristic and palmitic acids correlated positively with waist circumference.
HDL-cholesterol correlated with many individual FAs; ALA, all MUFAs, and myristic and palmitic
acids correlated negatively with HDL, whereas EPA, DPA, DHA, LA, AA, and stearic acid correlated
positively with HDL. The opposite pattern was observed for triglycerides, with strong negative
correlations with DHA, LA, AA, and stearic acid and positive correlations with ALA, all MUFAs,
and myristic and palmitic acids.
D6D, D9D, and SCD correlated positively, but D5D negatively, with BMI, waist and hip
circumference, % body fat, and levels of LDL and triglycerides. The reverse was seen for HDL,
which correlated negatively with D6D, D9D, and SCD, but positive with D5D.
There were no correlations between individual FAs or desaturases and age (data not shown).
Table 4. Correlations of serum fatty acids with anthropometric measurements and blood lipids for all
women. R = Pearson correlation coefficient. Significant correlations (p < 0.05) are displayed in bold.
BMI Systolic BP Diastolic BP Waist Hip Body Fat % HDL LDL TG
n = 221 n = 220 n = 220 n = 218 n = 218 n = 85 n = 221 n = 221 n = 220
ω-3 PUFAs
ALA (18:3n3)
R 0.109 −0.013 −0.033 0.114 0.072 0.120 −0.325 0.170 0.385
P 0.106 0.850 0.629 0.092 0.291 0.275 <0.001 0.011 <0.001
EPA (20:5n3)
R −0.045 0.075 0.062 −0.080 −0.075 −0.019 0.161 <0.001 −0.179
P 0.506 0.269 0.356 0.239 0.270 0.860 0.016 0.998 0.008
DPA (22:5n3)
R −0.101 −0.034 −0.022 −0.117 −0.098 −0.146 0.161 −0.043 −0.059
P 0.134 0.620 0.743 0.085 0.149 0.181 0.017 0.527 0.386
DHA (22:6n3)
R −0.196 −0.059 −0.040 −0.180 −0.221 −0.162 0.306 −0.126 −0.275
P 0.003 0.384 0.556 0.008 0.001 0.138 <0.001 0.061 <0.001
ω-6 PUFAs
LA (18:2n6)
R −0.265 −0.163 −0.184 −0.202 −0.184 −0.247 0.232 −0.060 −0.549
P <0.001 0.016 0.006 0.003 0.006 0.023 0.001 0.376 <0.001
GLA (18:3n6)
R 0.208 0.065 0.094 0.075 0.150 0.394 −0.063 0.208 0.049
P 0.002 0.334 0.166 0.273 0.027 <0.001 0.351 0.002 0.473
DGLA
(20:3n6)
R 0.223 0.076 0.052 0.209 0.216 0.289 −0.080 0.161 −0.035
P 0.001 0.261 0.447 0.002 0.001 0.007 0.235 0.017 0.603
AA (20:4n6)
R −0.019 0.054 0.048 −0.092 −0.004 −0.127 0.260 −0.120 −0.373
P 0.781 0.428 0.481 0.178 0.958 0.245 <0.001 0.076 <0.001
MUFAs
POA (16:1n7)
R 0.305 0.125 0.160 0.204 0.266 0.400 −0.176 0.206 0.511
P <0.001 0.063 0.017 0.002 <0.001 <0.001 0.009 0.002 <0.001
Vaccenic acid
(18:1n7)
R 0.104 0.034 0.078 0.009 0.085 0.078 −0.207 −0.008 0.335
P 0.124 0.618 0.246 0.891 0.213 0.480 0.002 0.907 <0.001
Oleic acid
(18:1n9)
R 0.228 0.115 0.150 0.214 0.205 0.246 −0.390 0.171 0.604
P 0.001 0.090 0.026 0.001 0.002 0.023 <0.001 0.011 <0.001
Saturated FAs
Myristic acid
(14:0)
R 0.130 0.030 0.043 0.161 0.057 0.154 −0.210 0.143 0.407
P 0.053 0.661 0.523 0.017 0.405 0.158 0.002 0.034 <0.001
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Table 4. Cont.
BMI Systolic BP Diastolic BP Waist Hip Body Fat % HDL LDL TG
n = 221 n = 220 n = 220 n = 218 n = 218 n = 85 n = 221 n = 221 n = 220
Palmitic acid
(16:0)
R 0.128 0.089 0.057 0.138 0.047 0.116 −0.149 −0.041 0.435
P 0.058 0.186 0.397 0.042 0.493 0.290 0.027 0.541 <0.001
Stearic acid
(18:0)
R −0.093 −0.075 −0.050 −0.123 −0.099 −0.111 0.266 −0.245 −0.379
P 0.167 0.270 0.461 0.069 0.144 0.313 <0.001 <0.001 <0.001
Desaturases
D6D
R 0.308 0.144 0.132 0.262 0.262 0.347 −0.174 0.174 0.235
P <0.001 0.033 0.051 <0.001 <0.001 0.001 0.010 0.010 <0.001
D5D
R −0.195 −0.037 −0.027 −0.222 −0.176 −0.264 0.226 −0.215 −0.209
P 0.004 0.583 0.695 0.001 0.009 0.015 0.001 0.001 0.002
SCD
R 0.316 0.120 0.169 0.198 0.286 0.441 −0.168 0.245 0.455
P <0.001 0.075 0.012 0.003 <0.001 <0.001 0.012 <0.001 <0.001
D9D
R 0.192 0.108 0.101 0.213 0.182 0.227 −0.400 0.229 0.655
P 0.004 0.112 0.134 0.002 0.007 0.037 <0.001 0.001 <0.001
AA, arachidonic acid; ALA, α-linolenic acid; BMI, body mass index; BP, blood pressure; D5D, delta-5 desaturase;
D6D, delta-6 desaturase; D9D, delta-9 desaturase; DGLA, dihomo-γ-linolenic acid; DPA, docosapentaenoic acid;
DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; GLA, γ-linolenic acid; HDL, high-density lipoprotein;
LA, linoleic acid; LDL, low-density lipoprotein; POA, palmitoleic acid; SCD, stearoyl-coenzyme A desaturase;
TG, triglycerides.
3.4. Correlation between FAs and Glucose Tolerance for All Women
Correlations between FAs and glucose and insulin measurements are shown in Table 5.
Amongst the ω-3 PUFAs, ALA correlated positively with all glucose and insulin measurements,
whereas DHA and DPA correlated negatively with AUC glucose and AUC insulin, respectively.
Forω-6-PUFAs, LA correlated inversely with all glucose and insulin measurements and with HbA1c.
Similarly, AA correlated inversely with fasting and AUC insulin and AUC glucose. DGLA, however,
correlated positively with fasting and AUC insulin. MUFAs were associated with high glucose and
insulin levels; POA correlated positively with AUC glucose and both fasting and AUC insulin, and oleic
acid with both fasting and AUC, glucose, and insulin. Saturated myristic and palmitic acids both
correlated positively with fasting insulin and AUC glucose and insulin. Palmitic acid correlated with
fasting glucose and HbA1c. All correlations of FAs with glucose and insulin measurements described
above remained significant after adjustment for BMI, whereas palmitic acid was the only variable that
correlated with HbA1c after adjustment (data not shown).
For the desaturases, D6D, SCD and D9D were positively correlated, and D5D negatively correlated,
with fasting insulin and both AUC glucose and insulin. Only D9D correlated with fasting glucose and
HbA1c. All of these relationships remained significant after adjustment for BMI.
A stepwise regression analysis was performed to predict the variance of insulin resistance
(HOMA-IR), using all fatty acids as independent variables. The final model resulted in an adjusted
R2 = 0.23 and included three FAs; LA (β = −0.40, p < 0.001), ALA (β = 0.27, p < 0.001) and DPA
(β = −0.17, p = 0.007).
An overview of the associations of FAs and desaturases with glucose and insulin metabolism,
and risk factors for metabolic syndrome, is presented in Figure 1.
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Table 5. Correlations of serum fatty acids (FAs) with glucose and insulin measurements for all women.
R = Pearson correlation coefficient. Significant correlations (p < 0.05) are displayed in bold.
Glucose
(Fasting)
Insulin
(Fasting) HOMA-IR HOMA-β-Cell
Glucose
AUC
Insulin
AUC HbA1c
n = 220 n = 216 n = 214 n = 214 n = 176 n = 166 n = 220
ω-3 PUFAs
ALA (18:3n3)
R 0.181 0.247 0.289 0.183 0.243 0.283 0.111
P 0.007 <0.001 <0.001 0.007 0.001 <0.001 0.100
EPA (20:5n3)
R 0.060 0.029 0.046 −0.030 −0.113 −0.120 0.003
P 0.374 0.676 0.504 0.665 0.137 0.125 0.969
DPA (22:5n3)
R 0.061 −0.121 −0.046 −0.200 −0.073 −0.169 0.032
P 0.368 0.077 0.501 0.003 0.333 0.030 0.634
DHA (22:6n3)
R 0.005 −0.126 −0.109 −0.131 −0.239 −0.149 −0.059
P 0.940 0.064 0.113 0.056 0.001 0.056 0.382
ω-6 PUFAs
LA (18:2n6)
R −0.239 −0.351 −0.395 −0.093 −0.346 −0.294 −0.164
P <0.001 <0.001 <0.001 0.177 <0.001 <0.001 0.015
GLA (18:3n6)
R 0.010 0.119 0.105 0.090 0.145 0.172 0.108
P 0.882 0.080 0.127 0.188 0.055 0.027 0.110
DGLA (20:3n6)
R −0.132 0.205 0.079 0.222 0.144 0.315 −0.117
P 0.051 0.002 0.250 0.001 0.056 <0.001 0.083
AA (20:4n6)
R −0.008 −0.187 −0.169 −0.196 −0.219 −0.220 −0.001
P 0.904 0.006 0.013 0.004 0.003 0.004 0.982
MUFAs
POA (16:1n7)
R 0.063 0.286 0.256 0.104 0.432 0.277 0.054
P 0.350 <0.001 <0.001 0.130 <0.001 <0.001 0.422
Vaccenic acid
(18:1n7)
R 0.055 0.084 0.108 <0.001 0.129 0.012 −0.024
P 0.420 0.220 0.114 0.995 0.088 0.878 0.719
Oleic acid
(18:1n9)
R 0.201 0.297 0.331 0.126 0.334 0.297 0.125
P 0.003 <0.001 <0.001 0.066 <0.001 <0.001 0.064
Saturated FAs
Myristic acid
(14:0)
R 0.059 0.253 0.256 0.168 0.298 0.304 0.062
P 0.380 <0.001 <0.001 0.014 <0.001 <0.001 0.357
Palmitic acid
(16:0)
R 0.175 0.239 0.292 0.081 0.273 0.180 0.188
P 0.009 <0.001 <0.001 0.240 <0.001 0.020 0.005
Stearic acid
(18:0)
R −0.117 −0.085 −0.125 −0.050 −0.176 −0.086 −0.132
P 0.084 0.212 0.068 0.465 0.020 0.270 0.051
Desaturases
D6D
R −0.016 0.331 0.232 0.216 0.290 0.392 −0.038
P 0.818 <0.001 0.001 0.002 <0.001 <0.001 0.578
D5D
R 0.101 −0.258 −0.152 −0.262 −0.256 −0.351 0.093
P 0.135 <0.001 0.026 <0.001 0.001 <0.001 0.167
SCD
R 0.011 0.268 0.214 0.110 0.411 0.279 −0.004
P 0.868 <0.001 0.002 0.107 <0.001 <0.001 0.949
D9D
R 0.234 0.227 0.300 0.083 0.340 0.239 0.203
P <0.001 0.001 <0.001 0.227 <0.001 0.002 0.003
AA, arachidonic acid; ALA, α-linolenic acid; AUC, area under the curve; D5D, delta-5 desaturase;
D6D, delta-6 desaturase; D9D, delta-9 desaturase; DGLA, dihomo-γ-linolenic acid; DPA, docosapentaenoic acid;
DHA, docosahexaenoic acid; EPA, eicosapentaenoic acid; GLA, γ-linolenic acid; HOMA-β-cell, homeostatic
model assessment of β-cell function; HOMA-IR, homeostatic model assessment of insulin resistance; LA,
linoleic acid; MUFA, monounsaturated fatty acid; POA, palmitoleic acid; PUFA, polyunsaturated fatty acid;
SCD, stearoyl-coenzyme A desaturase.
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Figure 1. Summary of results from serum fatty acid (FA) profiling in women 6 years after GDM. Arrows
shows whether the FA or desaturase had a positive (arrow up), or negative (arrow down) correlation
with glucose values (fasting or AUC), with insulin (fasting or AUC) after BMI adjustment, or with
at least two parameters of MetS (high BMI, low HDL cholesterol, high blood pressure, high waist
circumference, or high body fat percentage). AA, arachidonic acid; ALA, α-linolenic acid; AUC, area
under the curve; BMI, body mass index; D5D, delta-5 desaturase; D6D, delta-6 desaturase; D9D, delta-9
desaturase; DGLA, dihomo-γ-linolenic acid; DPA, docosapentaenoic acid; DHA, docosahexaenoic acid;
EPA, eicos pentaenoic acid; GLA, γ-linolenic acid; HDL, high-de sity lipoprotein; A, linoleic acid;
MUFA, monounsaturated fatty acid; POA, palmitoleic acid; PUFA, polyunsaturated fatty acid; SCD,
stearoyl-coenzyme A desaturase.
3.5. Correlations with Dietary Intake in All omen
Self-reported fish meal frequency correlated with EPA and DHA (r = 0.20, p = 0.01 for EPA;
r = 0.30, p < 0.001 for DHA), and it also correlated with level of education (r = 0.17, p = 0.04). eat meal
frequency correlated negatively with ALA (r = −0.25, p = 0.001) and vegetarian meal frequency
positively with stearic acid (r = 0.17, p = 0.03). Fish, meat, or vegetarian meal frequency, however,
did not correlate with any anthropometric measurement, with lipid, glucose or insulin values, or with
ethnicity (data not shown).
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Proportions of butter, margarine, and vegetable oil used showed several correlations, both with
serum FAs and with glucose tolerance and anthropometric data. Of special note were the positive
correlation between vegetable oil intake and LA (r = 0.19, p = 0.03), and the inverse correlation
between margarine intake and LA (r = −0.21, p = 0.02). The opposite pattern was seen for palmitic
acid, which correlated negatively with vegetable oil (r = −0.23, p = 0.006) and positively with
margarine intake (r = 0.18, p = 0.04). MUFAs generally correlated positively with margarine intake
(combined association r = 0.26, p = 0.002). Furthermore, glucose AUC correlated positively with
margarine intake (r = 0.21, p = 0.02), but negatively with both butter and oil intake (r = −0.18, p = 0.04
and r = −0.22, p = 0.02, respectively). For anthropometric and clinical measures, vegetable oil intake
correlated favourably with several parameters, amongst which were negative correlations with systolic
blood pressure (r = −0.27, p=0.002) and BMI (r = −0.22, p = 0.01), although a positive correlation was
seen with fat free mass (r = 0.25, p = 0.05).
3.6. FA Influence on T2D Development in Women Treated with Insulin during Pregnancy
Considering women who received insulin treatment during pregnancy as at high-risk of
developing T2D (n = 51), we evaluated which factors differed in those who developed (n = 21)
or had not developed T2D (n = 30) by the 6-year follow-up (Table 6). Among the fatty acids,
LA levels were significantly lower and palmitic acid levels significantly higher in women who had
developed T2D compared with those who had not. No other FA or desaturase differed between groups
(data not shown). There were also no between-group differences in terms of anthropometric data,
lipid measurements, ethnicity, or dietary intake.
Table 6. Characteristics of the subgroup of women at high risk of developing type 2 diabetes (T2D)
owing to the requirement for insulin treatment during GDM. This group was divided into women who
had or had not developed T2D by 6 years after pregnancy.
NGT or IGT (n = 32) T2D (n = 21) P
Mean SD Mean SD
Ethnicity (% Scandinavian) 29 27 0.57
BMI (kg/m2) 29.3 4.9 29.1 4.9 0.92
BMI change from pre-pregnancy (kg/m2) −1.27 3.82 −0.41 3.06 0.38
BP Systolic (mmHg) 121 13 120 12 0.72
BP Diastolic (mmHg) 78 9 78 9 0.81
Waist (cm) 96 10 95 14 0.81
Hip (cm) 108 10 107 10 0.82
s-HDL (mM) 1.33 0.33 1.33 0.50 0.96
s-LDL (mM) 3.20 0.66 3.04 0.63 0.38
s-Triglycerides (mM) 1.07 0.34 1.48 1.62 0.18
b-HbA1c (mmol/mol) 40 5 57 23 <0.001
p-Glucose fasting (mM) 5.8 0.4 9.0 4.3 0.001
Significantly different FAs:
Palmitic acid (16:0) 23.0 1.8 24.7 2.2 0.005
LA (18:2n6) 30.4 4.3 27.0 3.9 0.007
b, whole blood; BP, blood pressure; BMI, body mass index; FA, fatty acid; GDM, gestational diabetes mellitus;
HDL, high-density lipoprotein; IGT, impaired glucose tolerance; LA, linoleic acid; LDL, low-density lipoprotein;
NGT, normal glucose tolerance; p, plasma; s, serum; SD, standard deviation.
4. Discussion
In a population of women with previous GDM, distinct FA profiles were linked to glucose
intolerance and insulin resistance 6 years after pregnancy. A high level of LA correlated with high
consumption of vegetable oil and was consistently associated with a healthy metabolic profile,
as well as high insulin sensitivity, glucose tolerance, and a low incidence of T2D. D6D activity
correlated positively with measures of insulin resistance, and was increased in women with IGT
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and T2D, whereas D5D correlated negatively with insulin concentration, but activity levels did not
differ significantly between groups. Results forω-3 PUFAs were mixed, with only ALA correlating
positively with insulin resistance. Levels of saturated fatty acids, the desaturases SCD and D9D,
and corresponding MUFAs, correlated with margarine intake and were generally associated with
decreased metabolic health and glucose intolerance. In women with most severe cases of GDM in
which insulin treatment was needed during pregnancy, the development of T2D development was
linked to high levels of palmitic acid and low levels of LA. Taken together, these findings highlight
that LA concentrations after GDM may be a predictor of glucose tolerance and risk of developing T2D.
4.1. MUFAs and Saturated FAs Associate with Decreased Metabolic Health
Saturated FAs are high in the western-style diet and are linked to harmful metabolic profiles.
The role of MUFAs in metabolic health are, however, not as clear [30,31]. In our study, serum levels
of the MUFAs, POA and oleic acid, appear to be related to total body fat, whereas levels of saturated
FAs correlated with visceral fat (waist) only and not hip or overall fat. POA, oleic acid, myristic acid,
and palmitic acid were all associated with increased glucose intolerance and insulin resistance, and with
high use of margarine for cooking. Both MUFAs and saturated FAs were strongly linked to lipoprotein
and triglyceride levels. It should be noted that the concentration of these FAs not only depend on
intake from fat but also from de-novo lipogenesis during excessive calorie intake from other energy
sources, for example, if intake of refined sugars is high. We could not deduct from our dietary data the
most likely origin of high serum levels of saturated FAs as we did not see correlations with fat intake
or with mono- and disaccharide intake (data not shown). Furthermore, with margarine in Sweden
being mainly plant based, correlations between saturated FAs and proportion of margarine use might
be unexpected. There is, however, saturated fats such as palmitic acid present in plant oils and it is
also worth noting that the FFQ question on margarine, vegetable oil, and butter use was expressed as
proportions and not in absolute values.
In the current population, as in similar populations [32], the strongest predictor for T2D
development after GDM was the requirement for insulin treatment during pregnancy, which predicted
80.5% of T2D cases at the 6-year follow up [24]. We therefore considered women with insulin
treatment during pregnancy as a high risk group and looked at T2D development within this group.
Although there were no differences in BMI, anthropometry, lipoprotein, triglyceride, or ethnicity
between women, high levels of palmitic acid, together with low levels of LA, were characteristic
of women who had developed T2D from within this high-risk group. There were no significant
differences in dietary intake between groups in the high risk women (data not shown), though this
might partially be explained by a low number of dietary questionnaires accepted after the exclusion
criteria (n = 15 and n = 10 in groups NGT/IGT and T2D, respectively).
The discrepancy between previous reports of the overwhelming benefits of oleic acid intake [33],
and the detrimental associations between serum levels and diabetes risk [31,34], can partly be
explained by the simultaneously high activities of desaturases. When saturated FA levels are high,
desaturases convert these FAs to their unsaturated forms in order to reduce cell toxicity. D9D activity,
converting stearic acid to oleic acid, correlates strongly both with anthropometric measures and glucose
metabolism in our study, and could therefore be responsible for the production of high oleic acid
levels seen with increased body fat and insulin resistance. Similarly, high levels of POA in insulin
resistance could be explained by increased activity of SCD. It is also worth noting that in Northern
and Western Europe, oleic acid intake is often derived from dairy and meat sources, and is therefore
strongly linked to saturated FA intake [35], again pointing to the importance of studying both FA
intake and circulating FA levels in different populations.
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4.2. LA Is Robustly Associated with Healthy Glucose Homeostasis
LA is the most abundant of the PUFAs, and the decrease in LA levels in the T2D and IGT groups
largely confirms results from previous studies [15,16,19,36]. LA was inversely associated with all
anthropometric measures, and correlated strongly with both fasting and AUC, glucose and insulin,
before and after adjustment for BMI. Furthermore, decreased LA was the strongest predictor of insulin
resistance (HOMA-IR) in our regression model. LA was also low in women who developed T2D in
our high-risk subgroup.
Low LA levels are either a result of low dietary intake of LA or increased breakdown of LA
(via D6D activity), or a combination of the two [13]. We saw a correlation between LA serum
concentration and vegetable oil intake. But, we also found increased D6D activity to be associated
with T2D for the GDM population as a whole, suggesting a combination of low LA intake and high
breakdown. In our high-diabetes-risk population, however, there was no difference in D6D or in
downstream FAs between those that developed T2D and those that did not, supporting the argument
that intake of LA might be decisive. This is also supported by the finding of an inverse association
between AUC glucose levels and vegetable oil intake in the whole population.
Inverse correlations of AA levels with glucose and insulin, in agreement with studies in other
populations [37,38], further supports the link between highω6-PUFA proportions and lower risk for
insulin resistance. DGLA, however, correlated in a positive manner with insulin levels, both fasting
and AUC. D6D converts LA to DGLA and has been suggested to be activated at high insulin levels [39],
which could explain the association we see between high insulin levels and DGLA. As seen in other
studies, DGLA was also associated quite strongly with BMI, waist circumference, and body fat [31,40].
4.3. ω3-PUFAs Show Mixed Results in Relation to Glucose Metabolism
As expected, we found that high fish intake led to higher serum levels of EPA and DHA.
Although there was no difference in EPA or DHA between glucose tolerance groups, there was
an inverse correlation between glucose AUC and DHA, and DHA in particular was associated with
good metabolic health, as seen in correlations with anthropometric measured, HDL and triglycerides.
Fish oil supplementation has been shown to be beneficial to metabolic health, and our results add to
some previous evidence of an association between DHA, in particular, and increased insulin sensitivity,
although results are not clear cut [9,41]. ALA has been studied less than DHA and EPA, but the
few studies on serum ALA levels have shown either no association with glucose levels and T2D
incidence [14,15], or in one case an inverse association with T2D [16]. Surprisingly, we found that high
ALA levels correlated with high concentrations of both glucose and insulin. To our knowledge, such an
association has not been shown before. The correlation with glucose, however, was only observed
within the T2D group and not the NGT or IGT groups (data not shown). The mixed results in previous
studies could therefore be explained by between-cohort differences in terms of glucose tolerance and
diabetes progression. It is, however, worth noting that ALA is rapidly oxidized [42] and has a very
low abundance in serum (less than 1% of total FAs - approximately 50 times lower concentration than,
for example, LA). This may make correlation analysis and conclusions regarding ALA precarious.
A recent systematic review showed that the relationship between PUFA intake, individual FA
serum levels and diabetes risk is linked to polymorphisms of the genes expressing D5D and D6D
(FADS1 and FADS2, respectively). High D5D activity and low D6D activity is suggested to play a
protective role in the development of diabetes, where these activities are influenced both by FA intake
and gene polymorphisms. For example, high intake ofω-3 PUFAs improved HOMA-IR for subjects
with some FA desaturate (FADS) gene variants, whereas it increased fasting glucose for carriers of a
minor FADS2 allele [11].
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4.4. Strengths and Limitations
Few studies have used an OGTT to evaluate glucose tolerance and insulin levels in relation to
FA profile. Studies in the field have generally used fasting glucose or clinical diagnosis of T2D as
outcome measures. In addition, previous research on individual FAs in relation to glucose metabolism
has mainly been conducted in middle-aged or elderly populations with no identified underlying
risk for T2D [14–16]. The women in our study are relatively young and have a sevenfold increased
risk of developing T2D compared with women with no previous GDM [43]. The study includes
a well-characterized cohort with a broad range of different levels of glucose tolerance. Use of a
cohesive single-sex cohort with a narrow age span has the advantage that many variables are already
controlled for, but means that there are limitations when extrapolating the results to an extended
population. The study is cross-sectional with lipid profile measured at only one time point, making it
difficult to determine causality. To evaluate risk of diabetes development further, data collection at
additional time points would be desirable. There could potentially be genetic confounders affecting
the relationship between FAs and glucose tolerance. We have chosen to adjust analysis for BMI
but not for ethnicity or family history of diabetes since this data, collected from medical records,
was uncertain for many women. However, if further adjusting for known heredity and ethnicity based
on our available data, all significant BMI adjusted differences were still significant (data not shown).
We have further chosen to measure total FA fractions in serum and previous results have indicated that
results from different circulating fractions show good agreement [44]. Furthermore, in line with most
other reports, we decided to express FAs as a percentage of total FAs rather than as absolute values.
Using percentages of FAs also gives the advantage of relatively strong agreement between dietary
intake and serum levels for LA, EPA, and DHA [10]. ALA serum levels, however, correlate weakly
with dietary intake [10].
5. Conclusions
Given the high incidence of T2D in women with previous GDM, it is of great interest to find links
between FA metabolism and glucose tolerance during the transition from GDM to T2D, both in order
to predict disease progression and enable clinicians to give evidence-based advice. Our results show
that proportions of serum LA and palmitic acid are particularly important predictors of diabetes risk,
suggesting that an increase in dietary LA intake could be beneficial. Our finding that vegetable oil
consumption correlated positively with LA serum levels and OGTT glucose levels in this group further
supports this idea. The role of desaturase activities in the promotion of an optimal balance between
different FAs which might influence the risk for developing T2D and IGT warrants further study.
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